These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28899088)

  • 1. Identification of Siglec Ligands Using a Proximity Labeling Method.
    Chang L; Chen YJ; Fan CY; Tang CJ; Chen YH; Low PY; Ventura A; Lin CC; Chen YJ; Angata T
    J Proteome Res; 2017 Oct; 16(10):3929-3941. PubMed ID: 28899088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
    Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Siglec Cis-Ligands by Proximity Labeling.
    Alborzian Deh Sheikh A; Akatsu C; Tsubata T
    Methods Mol Biol; 2020; 2132():75-83. PubMed ID: 32306316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Recombinant Siglecs and Identification of Their Ligands.
    Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
    Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
    Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
    J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
    Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
    J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
    Tsubata T
    Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
    Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
    J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec cis-ligands and their roles in the immune system.
    Tsubata T
    Glycobiology; 2023 Aug; 33(7):532-544. PubMed ID: 37154567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lectin counter-receptors on cell membranes by proximity labeling.
    Wu G; Nagala M; Crocker PR
    Glycobiology; 2017 Sep; 27(9):800-805. PubMed ID: 28810661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
    Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
    Front Immunol; 2018; 9():820. PubMed ID: 29725338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
    Müller J; Nitschke L
    Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.
    Yoshimura A; Asahina Y; Chang LY; Angata T; Tanaka H; Kitajima K; Sato C
    J Biol Chem; 2021; 296():100477. PubMed ID: 33640457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
    Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
    Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.